HB
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Prevalence and factors associated with severe fatigue 2 years into the COVID-19 pandemic : a cross-sectional population-based study in Geneva, Switzerland | BMJ open |  | 2025 | 85 | 77 | ||
| Covid-19 pandemic-related changes in teleworking, emotional exhaustion, and occupational burnout : a cross-sectional analysis of a cohort study | BMC public health | | 2025 | 71 | 117 | ||
| Association between SARS-CoV-2 infection and anti-apolipoprotein A-1 antibody in children | Frontiers in immunology | | 2025 | 47 | 47 | ||
| Acne-Related Quality of Life and Mental Health Among Adolescents : A Cross-Sectional Analysis | Clinical and experimental dermatology | | 2024 | 98 | 192 | ||
| Patient-Perceived Impact of the COVID-19 Pandemic on Medication Adherence and Access to Care for Long-Term Diseases : A Cross-Sectional Online Survey | COVID | | 2024 | 84 | 70 | ||
| Impact of the COVID-19 pandemic on children and adolescents: determinants and association with quality of life and mental health—a cross-sectional study | Child and adolescent psychiatry and mental health | | 2023 | 174 | 113 | ||
| Changes in socioeconomic resources and mental health after the second COVID-19 wave (2020–2021) : a longitudinal study in Switzerland | International journal for equity in health | | 2023 | 123 | 93 | ||
| Socioeconomic conditions and children's mental health and quality of life during the COVID-19 pandemic : An intersectional analysis | SSM, population health | | 2023 | 151 | 86 | ||
| Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study | The Lancet regional health. Europe | | 2023 | 173 | 144 | ||
| Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study | Infection | | 2023 | 102 | 76 | ||
| Long term anti-SARS-CoV-2 antibody kinetics and correlate of protection against Omicron BA.1/BA.2 infection | Nature communications | | 2023 | 144 | 56 | ||
| Development of hybrid immunity during a period of high incidence of Omicron infections | International journal of epidemiology | | 2023 | 85 | 97 | ||
| Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland | BMJ open | | 2022 | 227 | 78 | ||
| Determinants of adolescents' Health-Related Quality of Life and psychological distress during the COVID-19 pandemic | PloS one | | 2022 | 167 | 146 | ||
| Persistent symptoms after SARS-CoV-2 infection in children: a cross-sectional population-based serological study | BMJ open | | 2022 | 114 | 45 | ||
| A population-based serological study of post-COVID syndrome prevalence and risk factors in children and adolescents | Nature communications | | 2022 | 215 | 83 | ||
| COVID-19-related school disruptions and well-being of children and adolescents in Geneva | Journal of paediatrics and child health | | 2022 | 150 | 113 | ||
| Forgoing healthcare during the COVID-19 pandemic in Geneva, Switzerland – A cross-sectional population-based study | Preventive medicine | | 2022 | 215 | 223 | ||
| Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021 | Euro surveillance | | 2021 | 261 | 127 | ||
| Insights into household transmission of SARS-CoV-2 from a population-based serological survey | Nature Communications | | 2021 | 436 | 187 | ||
| Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland | Nature Communications | | 2021 | 259 | 141 | ||
| Association between SARS-CoV-2 Seroprevalence in Nursing Home Staff and Resident COVID-19 Cases and Mortality: A Cross-Sectional Study | Viruses | | 2021 | 275 | 98 | ||
| Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak | The Lancet Infectious Diseases | | 2021 | 307 | 191 | ||
| Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study | Scandinavian journal of public health | | 2021 | 346 | 140 | ||
| Perceptions of vaccination certificates among the general population in Geneva, Switzerland | Swiss medical weekly | | 2021 | 101 | 85 | ||
| Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study | The Lancet |  | 2020 | 772 | 14 | ||
| Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland | International Journal of Public Health | | 2020 | 297 | 93 | ||
| A twelve-year study of the prevalence, risk factors and characteristics of interval colorectal cancers after negative colonoscopy | Clinics and research in hepatology and gastroenterology | | 2020 | 112 | 86 | ||
| La pharmacie clinique en milieu hospitalier : une enquête de satisfaction auprès des prescripteurs | Annales pharmaceutiques françaises | | 2017 | 75 | 0 | ||
| Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies | BMJ | | 2005 | 175 | 0 | ||
| Exposition domestique au radon et risque de cancer du poumon: Les résultats d’une étude épidémiologique menée en France | Revue des maladies respiratoires | | 2005 | 59 | 0 | ||
| Indoor radon and lung cancer in France | Epidemiology | | 2004 | 74 | 0 | ||
| Seasonal correction factors for estimating radon exposure in dwellings in France | Radiation protection dosimetry | | 2003 | 67 | 0 |
